← Open Payments lookup

LAUREN WILSON: Open Payments

NPI 1861847113 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$335 in 15 payments from 10 companies in 2025. Trend: 2023 $1,182 · 2024 $1,638 · 2025 $335

Food & beverage: $335
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.3$68
Vanda Pharmaceuticals Inc.3$59
ABBVIE INC.2$46
E.R. Squibb & Sons, L.L.C.1$32
Axsome Therapeutics, Inc.1$27
Janssen Pharmaceuticals, Inc1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Takeda Pharmaceuticals U.S.A., Inc.1$19
Otsuka America Pharmaceutical, Inc.1$19
Neurocrine BioSciences, Inc.1$17

Products named: UZEDY, FANAPT, VRAYLAR, COBENFY, Auvelity, INVEGA SUSTENNA, CAPLYTA, TRINTELLIX.

Industry payments across TX — which companies pay providers there.